retatrutide phase 3 trials Lilly's triple agonist delivers up to 71.2 lbs of weight loss Retatrutide Phase 3: TRIUMPH Program

Primary Care Physicians Versus Specialist Prescribers Primary care physicians manage the majority of GLP-1 prescriptions nationally, particularly for weight management

It simply needs to happen at the right time

Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study

From a health plan perspective, lifestyle resources (e.g., fitness programs incentives, lifestyle coaching) are not as highly utilized but are the most effective for weight loss management

The medication is administered via a subcutaneous injection once weekly

claims-based analysis found approximately a 33% lower risk of Alzheimers disease and related dementias among GLP-1 users compared with patients treated with other glucose-lowering therapies [9]